Lisa Haile > DLA Piper LLP (US) > San Diego (Golden Triangle), United States > Lawyer Profile
DLA Piper LLP (US) Offices
4365 EXECUTIVE DRIVE
SUITE 1100
SAN DIEGO, CA 92121-2133
CALIFORNIA
United States
- Firm Profile
- Go to...
Lisa Haile
Work Department
Patent Prosecution and Strategic Patent Counseling; Intellectual Property and Technology; Corporate; Regulatory and Government Affairs; Litigation, Arbitration and Investigations; Patent Litigation; Trademark and Copyright; Life Sciences; Healthcare; Energy and Natural Resources; Consumer Goods, Food and Retail
Position
Partner
Career
Dr. Lisa Haile concentrates on patent protection and IP transactional matters.
Dr. Haile has special technical experience in molecular biology, immunology, cell biology, regenerative medicine including ESCs, iPSCs, pSCs, gene editing, immuno-oncology, diagnostics, therapeutics, theranostics, drug delivery systems, host-vector systems, high throughput screening, and bioinformatics. She has particular experience with patentability, non-infringement and validity opinions; licensing strategies; FDA counseling; due diligence work in connection with venture capital, private and public financing; mergers and acquisitions in the life sciences industry; and strategic counseling for comprehensive life sciences patent portfolio management.
Memberships
San Diego Intellectual Property Law Association; American Intellectual Property Law Association; Intellectual Property Owners Association
Education
J.D., California Western School of Law; Ph.D, Georgetown University School of Medicine; B.A., Rollins College
Lawyer Rankings
United States > Intellectual property > Patents: licensing
(Leading lawyers)DLA Piper LLP (US)
acts on behalf of global companies involved in numerous industries and sectors in relation to patent transactions, technologies regarding patent licensing as well as transactions involving covenants. The firm advises clients on patent licensing transactions to settle patent litigation, also possessing expertise in the creation, management and monetization of patent portfolios. Notably, the firm also advises technology clients on patent licensing in connection with M&A, which includes the sale of assets, among others. Its matters encompass a variety of jurisdictions, such as the UK and Germany, with an ability to handle issues on a global market scale. Boston’s Larissa Bifano is experienced in patenting and licensing artificial intelligence driven systems and methods for clients. Victoria Lee, who is based in Silicon Valley, contributes a wide range of expertise, including strategic IP counselling, licensing agreements and technology spin-outs from universities. Alongside them, Sean Cunningham, who is based in the firm’s San Diego office, and Gina Durham, who is based in the firm’s San Francisco office, also lead the team. San Diego’s Lisa Haile concentrates on patent protection and IP transactional matters.
Lawyer Rankings
- Leading lawyers United States > Intellectual property > Patents: licensing
- Patents: licensing United States > Intellectual property
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Industry focus > Cannabis
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Intellectual property > Copyright
- Environment > Environment: regulatory
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Dispute resolution > Corporate investigations and white-collar criminal defense